Squarepoint Ops LLC Invests $650,000 in Innospec Inc. $IOSP

Squarepoint Ops LLC acquired a new stake in Innospec Inc. (NASDAQ:IOSPFree Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,727 shares of the specialty chemicals company’s stock, valued at approximately $650,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in Innospec in the second quarter valued at approximately $28,000. EverSource Wealth Advisors LLC lifted its position in shares of Innospec by 1,159.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock worth $44,000 after buying an additional 487 shares during the last quarter. Blue Trust Inc. boosted its holdings in shares of Innospec by 38.3% in the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company’s stock valued at $57,000 after buying an additional 186 shares in the last quarter. State of Wyoming grew its position in shares of Innospec by 27.5% in the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock valued at $67,000 after buying an additional 173 shares during the last quarter. Finally, Banque Transatlantique SA purchased a new position in shares of Innospec in the 1st quarter valued at $196,000. Institutional investors and hedge funds own 96.64% of the company’s stock.

Analyst Ratings Changes

IOSP has been the subject of several research analyst reports. Zacks Research downgraded shares of Innospec from a “hold” rating to a “strong sell” rating in a research note on Tuesday, November 4th. Wall Street Zen raised Innospec from a “hold” rating to a “buy” rating in a report on Saturday, December 13th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Innospec in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold”.

Get Our Latest Research Report on Innospec

Innospec Stock Performance

Shares of Innospec stock opened at $78.08 on Wednesday. The company has a market capitalization of $1.93 billion, a P/E ratio of -2,602.67 and a beta of 0.93. Innospec Inc. has a 1 year low of $70.10 and a 1 year high of $117.08. The company’s fifty day moving average is $74.97 and its two-hundred day moving average is $80.24.

Innospec (NASDAQ:IOSPGet Free Report) last announced its earnings results on Wednesday, November 5th. The specialty chemicals company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.09. The business had revenue of $441.90 million during the quarter, compared to the consensus estimate of $443.00 million. Innospec had a negative net margin of 0.07% and a positive return on equity of 10.28%. The business’s quarterly revenue was down .3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.35 earnings per share. As a group, equities analysts expect that Innospec Inc. will post 6.18 earnings per share for the current year.

Innospec Dividend Announcement

The business also recently announced a dividend, which was paid on Wednesday, November 26th. Stockholders of record on Tuesday, November 18th were issued a $0.87 dividend. The ex-dividend date of this dividend was Tuesday, November 18th. This represents a dividend yield of 245.0%. Innospec’s payout ratio is presently -5,800.00%.

Insider Activity at Innospec

In related news, Director Leslie J. Parrette purchased 340 shares of the firm’s stock in a transaction that occurred on Friday, November 14th. The stock was purchased at an average cost of $74.09 per share, with a total value of $25,190.60. Following the completion of the acquisition, the director directly owned 5,837 shares in the company, valued at $432,463.33. This trade represents a 6.19% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 1.31% of the stock is owned by company insiders.

Innospec Profile

(Free Report)

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.

Read More

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.